OS Therapies Inc. OSTX announced a statistically significant three-year overall survival benefit for patients treated with OST-HER2 in its Phase 2b trial. The study evaluated the prevention or delay ...

The U.S. Food and Drug Administration (FDA) has determined that a CBD- and THC-based drug being developed to control bone ...

A new study reveals that an AURKA-driven phosphorylation and SUMOylation cascade stabilizes the protein SPICE1, fueling ...

The spread of cancer from a primary tumor to another place in the body, called metastasis, remains one of the greatest ...

Jon Batiste's wife Suleika Jaouad—who was diagnosed with leukemia in 2010—shared an update on her cancer journey, revealing ...

Two weeks. That was how much time Hong Maly thought she had left. At 23, she was facing acute myeloid leukemia (AML), a ...

Holly LaPrade now hopes to raise awareness for the rare genetic condition known as fibrodysplasia ossificans progressiva (FOP ...

Jon Batiste‘s wife Suleika Jaouad is sharing a new health update amid her cancer battle. If you were unaware, the […] ...

The second cycle of chemotherapy. Since yesterday, the patient's complexion has not been good. Their platelet count is also ...

Lady A singer Charles Kelley reveals his multiple myeloma diagnosis following unexpected rib fractures. Discover how the ...

Today, the National Comprehensive Cancer Network® (NCCN®) published the first-ever edition of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Bone Sarcoma.

Companies to Meet Formally with FDA’s Center for Veterinary Medicine on November 19th for Pre-Submission Conference; U.S. Manufacturing Strategy Underway to Support Potential 2027 Veterinary Product L ...